Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Picower Institute presents new immunotherapeutic anticancer agents

March 17, 2000

Antisoma takes up another product from ICRF for clinical development

March 17, 2000

Low-dose M-Vax shows promise in stage III metastatic melanoma

March 17, 2000

Seattle Genetics updates MAb program

March 17, 2000

IND filed by NeoPharm for glioblastoma treatment

March 16, 2000

OvaRex shows evidence of cellular immune response

March 14, 2000

The FDA approves Pacis immunotherapy for treatment of bladder cancer

March 13, 2000

SciClone's Zadaxin boosts immune recognition of tumor cells

March 8, 2000

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Antitumor immunity induced by elemene involves enhancement of HSP70 expression

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...